Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of liposomal tretinoin in treating patients who have recurrent or refractory Hodgkin's disease.

Timeline

Start

1999-09

Primary completion

2001-01

Completion

—

Drugs

Indications